Umbria

In Umbria region 67,5% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 13 cases of cervicocarcinoma and 6 related deaths and thus results to be cost-...

Full description

Saved in:
Bibliographic Details
Published inFarmeconomia: Health Economics and Therapeutic Pathways Vol. 9; no. 1S; pp. 51 - 53
Main Authors Maria Caterina Cavallo, Filippo Cipriani, Simone Gerzeli, Nadia Demarteau, Alessia Marocco, Francesco Bamfi
Format Journal Article
LanguageEnglish
Italian
Published SEEd Medical Publishers 15.09.2008
Subjects
economic & clinical impact
hpv vaccination
umbria
Online AccessGet full text

Cover

More Information
Summary:In Umbria region 67,5% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 13 cases of cervicocarcinoma and 6 related deaths and thus results to be cost-effective (23.398 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 13 cancer cases and 5 deaths could be prevented, with a very similar cost-effectiveness ratio. In Umbria region, the net cost for woman vaccinated is 155 € for the single cohort and 159 € for the multiple cohort.
ISSN:2240-256X
DOI:10.7175/fe.v9i1S.1009